Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003154788 | SCV003843715 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246188 | SCV005017293 | uncertain significance | Inborn genetic diseases | 2023-09-25 | criteria provided, single submitter | clinical testing | The p.C356Y variant (also known as c.1067G>A), located in coding exon 9 of the BUB1B gene, results from a G to A substitution at nucleotide position 1067. The cysteine at codon 356 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |